I. Introduction
Brief Overview of Iressa (Gefitinib)
Importance of Targeted Cancer Therapies
Scope of the Article
II. Composition of Iressa
Chemical Composition
Active and Inactive Ingredients
III. How Iressa Works
Mechanism of Action
Target Cells and Processes
Comparison with Traditional Chemotherapy
IV. Approved Uses of Iressa
Treatment of Non-Small Cell Lung Cancer (NSCLC)
Criteria for Patient Eligibility
Success Rates and Clinical Studies
V. Off-Label Uses of Iressa
Potential Applications in Other Cancers
Current Research and Clinical Trials
Ethical Considerations
VI. Dosage and Administration
Recommended Dosage
Administration Guidelines
Adjustments for Specific Patient Groups
Special Dosage Considerations for the Elderly
Monitoring and Follow-up
Potential Risks and Benefits for Pregnant Women and Nursing Mothers
Alternative Therapies
Pediatric Dosing and Safety
Current Research on Pediatric Use
VII. Common Side Effects
Most Frequently Observed Side Effects
Management and Mitigation Strategies
VIII. Important Precautions and Warnings
Contraindications
Pre-existing Conditions and Cautions
Careful Administration
Patient Groups that Require Careful Monitoring
Situations Where Dosage Adjustment May Be Necessary
Overdosage
Signs and Symptoms
Emergency Management Procedures
IX. Drug Interactions
Known Drug Interactions
Recommendations for Concurrent Medication Use
X. Storage and Handling Precautions
Recommended Storage Conditions
Proper Handling and Disposal Guidelines
XI. Conclusion
Summary of Key Points
